PharmaCorp Rx Balance Sheet

Financials in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	5.02	12.89	2.24	2.73	0.98
Cash & Short-Term Investments	5.02	12.89	2.24	2.73	0.98
Cash Growth	-81.16%	474.84%	-17.99%	178.91%	-
Receivables	0.79	0.33	-	-	-
Inventory	2.46	1.31	-	-	-
Prepaid Expenses	0.19	0.05	-	-	-
Other Current Assets	-	-	0.08	-	0.02
Total Current Assets	8.46	14.57	2.32	2.73	1
Property, Plant & Equipment	4.23	4.02	-	-	-
Goodwill	14.03	11.48	-	-	-
Other Intangible Assets	7.95	5.13	-	-	-
Total Assets	39.71	35.21	2.32	2.73	1
Accounts Payable	2.84	1.54	0.05	0.02	0.03
Current Portion of Long-Term Debt	0.4	0.08	-	-	-
Current Portion of Leases	0.09	0.07	-	-	-
Current Income Taxes Payable	0.01	0.01	-	-	-
Total Current Liabilities	3.34	1.7	0.05	0.02	0.03
Long-Term Debt	3.15	0.32	-	-	-
Long-Term Leases	0.68	0.49	-	-	-
Long-Term Deferred Tax Liabilities	2.33	2.14	-	-	-
Total Liabilities	9.5	4.64	0.05	0.02	0.03
Common Stock	31.7	31.7	2.8	2.74	1
Additional Paid-In Capital	0.88	0.67	0.49	0.52	-
Retained Earnings	-2.6	-2.03	-1.01	-0.54	-0.03
Total Common Equity	29.98	30.34	2.27	2.72	0.97
Minority Interest	0.23	0.22	-	-	-
Shareholders' Equity	30.21	30.57	2.27	2.72	0.97
Total Liabilities & Equity	39.71	35.21	2.32	2.73	1
Total Debt	4.32	0.95	-	-	-
Net Cash (Debt)	0.71	11.93	2.24	2.73	0.98
Net Cash Growth	-97.25%	432.33%	-17.99%	178.91%	-
Net Cash Per Share	0.01	0.15	0.11	0.14	0.06
Filing Date Shares Outstanding	117.3	117.3	20.28	20	16.17
Total Common Shares Outstanding	117.3	117.3	20.28	20	16.17
Working Capital	5.12	12.88	2.27	2.72	0.97
Book Value Per Share	0.26	0.26	0.11	0.14	0.06
Tangible Book Value	8	13.73	2.27	2.72	0.97
Tangible Book Value Per Share	0.07	0.12	0.11	0.14	0.06
Land	0.25	0.25	-	-	-
Buildings	2.85	2.85	-	-	-
Machinery	0.26	0.13	-	-	-
Leasehold Improvements	0.31	0.31	-	-	-

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.